Clinical Trial: Study on the Mechanism and Effect of NK-1 and 5-HT3 Inhibitor Combination in the Treatment of Nausea and Vomiting Induced by Platinum-Containing Multi-week Chemotherapy (China)

China, Oct. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Mechanism and Effect of NK-1 and 5-HT3 Inhibitor Combination in the Treatment of Nausea and Vomiting Induced by Platinum-Containing Multi-week Chemotherapy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134502

Registration Time: 2026/10/15

Type: Interventional study

Primary Sponsor: Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=305769

Published by HT Digital Content Services with permission from Health Daily Digest....